ResearcherSeoul National UniversityNo recent work listed
Sang Min Lee
Matched on ORCID iD 0000-0001-7719-3849; OpenAlex author ID A5100342099. Sources: ClinicalTrials.gov.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2019: 1 paper · 2020: 2 papers · 2021: 1 trial · 2022: 2 papers · 2023: 1 paper
Papers 6
- Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Co-author DOI 10.1007/s00330-023-09959-5↗
- Accelerated Pancreatobiliary MRI for Pancreatic Cancer Surveillance in Patients With Pancreatic Cystic Neoplasms. Co-author DOI 10.1002/jmri.28189↗
- Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma. Co-author DOI 10.1007/s00330-022-08816-1↗
- Transcatheter arterial embolization for gastrointestinal bleeding related to pancreatic adenocarcinoma: clinical efficacy and predictors of clinical outcome. Co-author DOI 10.1016/j.ejrad.2019.108787↗
- Enhancement parameters of contrast-enhanced computed tomography for pancreatic ductal adenocarcinoma: Correlation with pathologic grading. Last author DOI 10.3748/wjg.v26.i28.4151↗
- Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement. Co-author DOI 10.1148/radiol.2019190422↗
Trials 1
- Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer Principal investigator NCT04969731↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tae Yeon Jeon · 2 shared papers, 2022–2023 · strength 0.40
- Paper Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenoca… DOI 10.1007/s00330-022-08816-1↗
- Paper Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review… DOI 10.1007/s00330-023-09959-5↗
- Sung‐Hoon Moon · 2 shared papers, 2022–2023 · strength 0.40
- Paper Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenoca… DOI 10.1007/s00330-022-08816-1↗
- Paper Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review… DOI 10.1007/s00330-023-09959-5↗
- Seung Bae Yoon · 2 shared papers, 2022–2023 · strength 0.40
- Paper Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenoca… DOI 10.1007/s00330-022-08816-1↗
- Paper Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review… DOI 10.1007/s00330-023-09959-5↗
- Jeong Min Lee · 2 shared papers, 2019–2022 · strength 0.24
- Eun Sun Lee · 2 shared papers, 2019–2022 · strength 0.24
- Myung‐Hwan Kim · 1 shared paper, 2022 · strength 0.20
- Moon Hyung Choi · 1 shared paper, 2023 · strength 0.19
- Dong Woo Shin · 1 shared paper, 2023 · strength 0.19
- Min-Jeong Kim · 1 shared paper, 2023 · strength 0.19
- Ji Hye Min · 1 shared paper, 2023 · strength 0.19
- Woorim Seo · 1 shared paper, 2020 · strength 0.16
- In Rae Cho · 1 shared paper, 2022 · strength 0.15
- Sun Kyung Jeon · 1 shared paper, 2022 · strength 0.15
- Jeong Hee Yoon · 1 shared paper, 2022 · strength 0.15
- Sang Hyub Lee · 1 shared paper, 2022 · strength 0.15
- Jae Seok Bae · 1 shared paper, 2022 · strength 0.15
- Cheng Shi Chen · 1 shared paper, 2020 · strength 0.12
- Sung Eun Park · 1 shared paper, 2020 · strength 0.12
- Dong Ho Lee · 1 shared paper, 2019 · strength 0.09
- Su Joa Ahn · 1 shared paper, 2019 · strength 0.09
- Ijin Joo · 1 shared paper, 2019 · strength 0.09
- Hyo‐Jin Kang · 1 shared paper, 2019 · strength 0.09
- Hyun Kyung Yang · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.